Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Community Pediatric Acceptability Study (CPAS) (CPAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02610699
Recruitment Status : Completed
First Posted : November 20, 2015
Last Update Posted : January 26, 2016
Sponsor:
Collaborators:
Georgia Institute of Technology
Children's Healthcare of Atlanta
Information provided by (Responsible Party):
Andi L. Shane, MD, Emory University

Brief Summary:

Ear infections, or otitis media, are a leading cause of health expenditures and antimicrobial prescriptions in children. Diagnosis of otitis media requires the ability to view the tympanic membrane. An instrument called an otoscope with a light source and a magnifying lens with a plastic tip that conforms to the ear canal is currently the standard of care for examining the tympanic membrane. Interpretation of otoscopic examinations is operator-dependent and cannot be seen by anyone other than the person holding the otoscope. A pocket size attachment that uses the technology and light source of a smartphone to capture images of the ear canal and tympanic membrane facilitates image documentation of the otic examination. In previous studies with the device, the investigators have shown that image quality of photographs of the tympanic membrane taken with the smartphone otoscope are equivalent to those taken with a camera-fitted conventional otoscope.

In this study, the Community Provider Assessment Study (CPAS), the investigators will perform a cross-sectional study in which they will randomly assign 3-4 pediatricians to use a smartphone otoscope as the standard of care device for all ear examinations and 3-4 pediatricians to use a conventional otoscope for alternating 1 month periods for 6 months. The parents of children examined during the study period with both devices will be invited to participate in 3 telephone surveys assessing parental satisfaction with the device and antimicrobial use by their child for the otic complaint. The results of this study have the potential to improve diagnosis and management of otitis media, thus improving patient care, reducing costs, and decreasing the opportunity for the development of antimicrobial resistance.


Condition or disease Intervention/treatment Phase
Otitis Other: Conventional otoscope Other: Smartphone otoscope Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 75 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: CellScope Oto - Community Pediatric Acceptability Study (CPAS)
Study Start Date : November 2014
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Antibiotics

Arm Intervention/treatment
Active Comparator: Smartphone otoscope/Conventional otoscope
Participating clinicians will use a smartphone otoscope for one month followed by a conventional otoscope for one month, alternating monthly, for a total of 6 months to examine children between 6 months and 18 years of age who have clinical signs of acute otitis media (AOM).
Other: Conventional otoscope
The conventional analogue otoscope will be used to provide a two-dimensional view of the ear canal. Clinicians will use this for one month periods for a total of 3 months.

Other: Smartphone otoscope
The smartphone otoscope is a pocket size smartphone attachment that uses technology and light source of a smartphone to capture reproducible images of the middle ear and tympanic membrane. Images and videos can be transmitted via real-time communication software from the device to another smartphone. Clinicians will use this for one month periods for a total of 3 months.
Other Name: CellScope-Oto

Active Comparator: Conventional otoscope/Smartphone otoscope
Participating clinicians will use a conventional otoscope for one month followed by a smartphone otoscope for one month, alternating monthly, for a total of 6 months to examine children between 6 months and 18 years of age who have clinical signs of acute otitis media (AOM).
Other: Conventional otoscope
The conventional analogue otoscope will be used to provide a two-dimensional view of the ear canal. Clinicians will use this for one month periods for a total of 3 months.

Other: Smartphone otoscope
The smartphone otoscope is a pocket size smartphone attachment that uses technology and light source of a smartphone to capture reproducible images of the middle ear and tympanic membrane. Images and videos can be transmitted via real-time communication software from the device to another smartphone. Clinicians will use this for one month periods for a total of 3 months.
Other Name: CellScope-Oto




Primary Outcome Measures :
  1. Rate of antibiotic prescription following otic examination with smartphone otoscope device compared to conventional otoscope device [ Time Frame: 4 weeks following enrollment ]
    The rate of antibiotic prescription will be assessed by a parent questionnaire. Parents will be asked if they felt comfortable watching and waiting before filling their child's antibiotic prescription. The number of prescriptions filled will be noted.


Secondary Outcome Measures :
  1. Time of antibiotic filling following otic examination with smartphone otoscope device compared to conventional otoscope device smartphone otoscope device compared to conventional otoscope device [ Time Frame: 4 weeks following enrollment ]
    The time of filling of the antibiotic prescription will be assessed by a parent questionnaire. Parents will be asked how long they waited before they filled their child's prescription and the response recorded.

  2. Rate of completion of antibiotic course following otic examination with smartphone otoscope device compared to conventional otoscope device [ Time Frame: 4 weeks following enrollment ]
    The rate of completion of the course of antibiotics will be assessed by a parent questionnaire. Parents will be asked if their child completed the course of prescribed antibiotics. The number of children who completed the entire course of antibiotics will be recorded.

  3. Acceptability of management plan following examination with smartphone otoscope device compared to conventional otoscope device [ Time Frame: 4 weeks following enrollment ]
    The acceptability of the management plan following examination with the smartphone otoscope as compared to conventional otoscope will be assessed by a parent questionnaire. A 'yes' response to questions relating to smartphone device images will indicate acceptability.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Months to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of an otic complaint
  • Willing to undergo otoscopy

Exclusion Criteria:

  • Unwilling or unable to to complete study telephone questionnaires
  • Do not meet inclusion criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02610699


Locations
Layout table for location information
United States, Georgia
Emory Children's Center
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Emory University
Georgia Institute of Technology
Children's Healthcare of Atlanta
Investigators
Layout table for investigator information
Principal Investigator: Andrea Shane, MD, MPH, MSc Emory University

Layout table for additonal information
Responsible Party: Andi L. Shane, MD, Associate Professor of Pediatrics, Emory University
ClinicalTrials.gov Identifier: NCT02610699     History of Changes
Other Study ID Numbers: IRB00074526
First Posted: November 20, 2015    Key Record Dates
Last Update Posted: January 26, 2016
Last Verified: January 2016